Good MorningEquity markets pulled back on Tuesday as concerns over the Middle East conflict intensified. President Trump, via social media, demanded the unconditional surrender of Iran's supreme leader and raised the risk of an all-out war. The takeaway, however, is that the underlying fundamentals remain bullish, and the S&P 500 is in a rebound and recovery mode, so any pullbacks that occur are unlikely to last or extend far.
The FOMC will drive Wednesday's action. The FOMC is expected to release its policy decision in the early afternoon and to leave interest rates unchanged. However, the Fed is also expected to provide clarity on the path of interest rates and may fail to satisfy the market. As it is, the market is pricing in a one-and-done scenario in which the Fed will cut a single time in 2025, sometime in late fall.
Featured: Elon’s BIGGEST warning yet? (Ad) 
|
Stocks | | | U.S. stocks are drifting higher on Wednesday as Wall Street waits to hear where the Federal Reserve may be taking interest rates.The S&P 500 was up 0.3% in afternoon trading. The Dow Jones Industrial Average was up 109 points, or 0.3%, as of 1:09 p.m. Eastern time, and the Nasdaq composite was 0... Read the Full Story |
|
From Our Partners | | The "TRUMP TRINITY" Just Triggered the Biggest Bitcoin Boom in History… and Could Send Bitcoin to $500,000
What a HUGE few months for Bitcoin!
Three massive breakthroughs just created the perfect storm for crypto profits...
I call it the "Trump Trinity" — and it's about to change everything. | | See how the Bitcoin Backdoor works. |
|
Markets | | |
Qualcomm Inc (NASDAQ: QCOM) closed just under $155 as the bell rang to end Tuesday's session, continuing to cool somewhat from last week's multi-month high. The pullback comes after shares gained more than 30% from April's low, marking one of Qualcomm's better rallies of the past year. But to ke... Read the Full Story |
|
Markets | | |
In another tragic incident, Sarepta Therapeutics (NASDAQ: SRPT) saw a second death in connection with its Duchenne muscular dystrophy (DMD) treatment ELEVIDYS. The patient passed away due to acute liver failure (ALF) after doctors treated them with ELEVIDYS. Sadly, the same thing happened t... Read the Full Story |
|
From Our Partners | | Between rising inflation, a $36 trillion national debt, and new tariffs hitting key industries, market volatility is once again on the rise.
In moments like these, many investors are re-evaluating their strategies—and turning to physical gold for protection.
We just released a new guide to help you navigate this environment:
📈 “How to Strengthen Your Portfolio with Physical Gold.” | | 👉 [Learn How To Invest in Gold Online Now] |
|
Markets | | |
CoreWeave Inc. (NASDAQ: CRWV) is among the top-performing stocks for 2025, despite completing its IPO only in late March of this year. With a year-to-date return of an incredible 330%, the company has rapidly become a go-to name for artificial intelligence infrastructure, cloud computing, and mach... Read the Full Story |
|
Markets | | | The inflation-fighters at the Federal Reserve are expected to keep their key interest rate unchanged Wednesday for the fourth straight time. That's likely to shift attention to how many interest rate cuts they forecast for this year. It's widely expected that the 19 Fed officials that participate in... Read the Full Story |
|
From Our Partners | | Renegade Trader Cracks
the Hidden “Code” of Wall Street
Target Extra Cash Every Day with a 90.2% Win Rate…
Did you know that the biggest secret on Wall Street is hiding in plain sight?
Most traders are completely unaware of it.
But once you crack their “secret code”, it could be the game-changer you’ve been waiting for.
Imagine the ability to target an extra $100 to $150 every single day, starting with just $1,000. Sounds incredible, right?
Today, renowned trader Chris Pulver is ready to guide you on this journey:
Discover Chris’s “Copy & Paste” Strategy | | Don’t miss out! Click here to discover Chris’s breakthrough approach and start your journey in makin |
|
Markets | | | A small, growing number of employers are putting health insurance decisions entirely in the hands of their workers.Instead of offering traditional insurance, they’re giving workers money to buy their own coverage in what’s known as Individual Coverage Health Reimbursement Arrangements, or ICHRAs.Adv... Read the Full Story |
|
Markets | | | Inflation in the U.K. dropped modestly in May as a drop in air fares and transport costs were largely offset by rising food prices, particularly chocolate, official figures showed Wednesday.The Office of National Statistics said consumer prices rose by 3.4% in the year to May, down from 3.5% the pre... Read the Full Story |
|
Markets | | |
Salesforce (NYSE: CRM) raised its prices, and its share price will soon follow for three reasons that begin and end with its pricing decision. The decision may appear to be bad news, impairing the company’s appeal to its consumers, but it aligns with technology industry trends and will ultim... Read the Full Story |
|
Markets | | | Nippon Steel and U.S. Steel say they've finalized their “historic partnership,” a year-and-a-half after the Japanese company first proposed its deal to buy the iconic American steelmaker for nearly $15 billion Read the Full Story |
|
Markets | | |
After an eye-watering recovery rally that saw it gain close to 70% in just a few weeks, Tesla Inc (NASDAQ: TSLA) is once again making its investors nervous. With CEO Elon Musk indicating towards the end of May that he was stepping back from White House duties to focus on the company, you'd be fo... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California. | Should I Buy Enovix Stock? ENVX Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Enovix was last updated on Wednesday, June 18, 2025 at 1:05 AM.
Enovix Bull Case -
Enovix Corporation has received multiple "buy" ratings from analysts, indicating strong confidence in its future performance. This includes a recent target price adjustment from Craig Hallum, which set a target of $18.00, suggesting potential upside from current levels.
-
The company reported a revenue of $9.72 million in its latest quarterly earnings, exceeding analysts' expectations of $8.77 million. This positive revenue performance can indicate strong demand for its products, which may lead to future growth.
-
Enovix Corporation operates in the rapidly growing lithium-ion battery market, which is essential for various industries, including electric vehicles and consumer electronics. This positions the company well to capitalize on increasing demand for advanced battery technologies.
-
The stock is currently trading at $8.07, which is significantly below its 52-week high of $18.68. This may present a buying opportunity for investors looking for undervalued stocks with growth potential.
-
With a market capitalization of $1.55 billion and a debt-to-equity ratio of 0.99, Enovix Corporation maintains a relatively healthy balance sheet, which can provide stability and reduce financial risk for investors.
Enovix Bear Case -
The company has a negative return on equity of 96.99% and a negative net margin of 963.17%, indicating that it is currently not profitable and may struggle to generate returns for shareholders in the near term.
-
Enovix Corporation's stock has recently experienced a decline of 2.8%, reflecting potential volatility and investor uncertainty regarding its future performance.
-
Despite positive revenue growth, analysts forecast a negative earnings per share (EPS) of -1.01 for the current fiscal year, suggesting that the company may continue to face challenges in achieving profitability.
-
Insider selling activity has been noted, with the CEO selling 300,000 shares, which could raise concerns among investors about the company's future prospects and insider confidence.
-
The average price target from analysts is $17.27, which is significantly higher than the current stock price, indicating that the market may have high expectations that could be difficult to meet.
| | View Today's Stock Pick |
|
